Form 4: REGENXBIO Director Acquires Shares and Options
Statement of Changes in Beneficial Ownership
REGENXBIO Inc. reports that Director Jean Bennett acquired 9,807 shares of common stock and was granted options for 46,600 shares.
Summary
- Director Jean Bennett acquired 9,807 shares of REGENXBIO Inc. common stock on May 29, 2026, valued at $0.00.
- Additionally, Bennett was granted stock options to purchase 46,600 shares of common stock at an exercise price of $7.01 per share.
- These options are set to vest on May 29, 2027, contingent upon continuous service to the issuer.
- The shares acquired are part of a restricted stock unit (RSU) award, with full vesting scheduled for May 29, 2027.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents routine insider transactions related to compensation and ownership rather than significant strategic or financial developments.
Positives
- Director Jean Bennett's acquisition of shares and options indicates continued commitment and investment in the company.
- The grant of stock options aligns the director's interests with those of shareholders, potentially incentivizing long-term value creation.
Future Outlook
The vesting of RSUs and stock options on May 29, 2027, suggests a forward-looking incentive structure tied to continued service and company performance.
Industry Context
StockSavvy.ai notes that the granting of stock options and RSUs to directors is a common practice in the biotechnology and pharmaceutical sectors to attract and retain key talent and align executive interests with shareholder value.
Stakeholder Impact
- Shareholders: The alignment of director incentives through stock options and RSUs can be viewed positively, as it links compensation to company performance and share value.
Next Steps
- Continuous service by Director Jean Bennett to meet vesting requirements for RSUs and stock options.
- Potential exercise of stock options upon vesting on May 29, 2027.
Key Dates
| Date | Description |
|---|---|
| 05/29/2026 | Transaction Date for acquisition of common stock and grant of stock options. |
| 05/29/2027 | Vesting date for the restricted stock unit award and the stock options. |
| 05/29/2036 | Expiration date for the granted stock options. |
| 06/02/2026 | Date of signature for the filing. |
Keywords
REGENXBIO Inc., RGNX, Form 4, Director, Stock Options, Restricted Stock Units, Beneficial Ownership, Securities Exchange Act
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.